Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice (Q56892297)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

based on heuristic

inferred from title

Ursula Dietrich

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Mingkui Zhou

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ioanna Kostoula

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Boris Brill

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Eugenia Panou

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Maria Sakarellos-Daitsiotis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

0 references

publication date

23 January 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1911-1916

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Passive immunization with human neutralizing monoclonal antibodies against HIV-1 in macaque models: experimental approaches.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

The role of antibodies in HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

AIDS/HIV. A boost for HIV vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Broad neutralization coverage of HIV by multiple highly potent antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

HIV vaccine development--improving on natural immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

A palmitoyl-tailed sequential oligopeptide carrier for engineering immunogenic conjugates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Synthetic carriers: sequential oligopeptide carriers SOCn-I and SOCn-II as an innovative and multifunctional approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Sequential oligopeptide carriers, SOCn, as scaffolds for the reconstitution of antigenic proteins: applications in solid phase immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Influenza virus H5N1 hemagglutinin (HA) T-cell epitope conjugates: design, synthesis and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

A synthetic peptide-based polyoxime vaccine construct of high purity and activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Unprotected peptides as building blocks for branched peptides and peptide dendrimers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Measuring HIV neutralization in a luciferase reporter gene assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

HIV vaccine design and the neutralizing antibody problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Artificial carriers: a strategy for constructing antigenic/immunogenic conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.01.026

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22269872%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56892297&oldid=1833388586"